Results

Total Results: 258 records

Showing results for "end stage renal".

121. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - in 2-3 doses; Extended- release, 100-200 mg/day RA: Delayed- release, 100-200 mg/day in 3- 4 Renal … impairment(CrCl >25 mL/min) max 150 mg/day; Moderate renal impairment (CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal endpoint or serious liver AEs. … update 9/16/02 Pain reduction 2 placebo controlled trials provided pain intensity at baseline and end

122. 2020 EPC Year in Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/2020-epc-year-in-review.pdf
     January 01, 2020 - End-stage Renal Disease in the Medicare Population: Frequency and Duration of Hemodialysis and Quality … Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease … Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer.

123. Methods Research Report - Framework for Determining Research Gaps During Systematic Review: Evaluation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-gaps_research.pdf
     February 01, 2013 - Health care research should begin and end with a systematic review.1-3 A comprehensive and explicit … to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … We have appended to end of instructions an example of a completed sheet. … to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal

124. AHRQ's Evidence-based Practice Center Division Annual Report 2020: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2020.pdf
     January 01, 2020 - End-stage Renal Disease in the Medicare Population: Frequency and Duration of Hemodialysis and Quality … Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease … Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer.

125. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Page 32, line 45: Missing “placebo” from the end of the first sentence. … Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal … Public Comment #3 (APA) Introduction p. 4 table disulfiram Suggest changing "at the acetaldehyde stage

126. Medicare Prescription Drug Data Development: Methods for Improving Patient Safety and Pharmacovigilance Using Observational Data | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/patient-safety-databases-prescriptions/research
     August 26, 2008 - MSMs are fitted in a two-stage process. … End date for enrollment interval. … Field Name: D2 Label: Interval End Date Definition: D2 is the end date for the interval. … Diabetes w/ chronic complications 31 HYPOTHY Num 3 Hypothyroidism 32 RENLFAIL Num 3 Renal … Field Description: Char (12) Field Name: serviceEndDate Label: Service End Date Definition: End

127. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated … Many surrogate/intermediate end points have not been adequately validated. … Just because there is enough information to pool a myriad of intermediate end points does not mean that … This completes the topic refinement project and sets the stage for the next phase, in which the key questions

128. Integrated Pain Management Programs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/integrated-pain-management/protocol
     November 10, 2020 - papers, citations that have not been peer-reviewed Abbreviations: ED = emergency department; ESDR = end … stage renal disease; HRQOL = Health-related quality of life; OT = occupational therapy; OUD = opioid … ED Emergency department EPC Evidence Based Practice Center ESDR End … stage renal disease HRQOL Health related quality of life IPMP Integrated pain … Key Informants Key Informants are the end-users of research; they can include patients and caregivers

129. Measuring-Blood-Pressure Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
     January 01, 2012 - One quality C study reported on mortality and end-stage renal disease. … lower mortality with SMBP plus self- titration versus usual care, and lower composite mortality and end-stage … renal disease. … End-stage renal disease alone was not significantly different.

130. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - 79 202 1 26 1 141 261 1 26 8 186 262 1 27 1 8 326 1 27 8 5 327 1 28 4 53 116 4 28 7 50 112 4 END … 1 1 7 NA 2 141 261 186 262 NA 1 1 8 NA 2 8 326 5 327 NA 1 1 8 NA 2 53 116 50 112 NA 1 4 7 NA 2 END … array x[3] x1-x3; do i=1 to 3; if i<= narm then x[i]=sqrt(0.5)*((i=index)-1/narm); else x[i]=0; end … RCT USA N: 413 Stage ≥3 pelvic organ prolapse, history of lower urinary tract surgery, lifelong … diabetes mellitus, demand cardiac pacemaker or intrauterine device use, genital prolapse greater than Stage

131. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Identify the existing systematic reviews and make a judgment about relevancy for the KQs, the end date … Both colchicine and NSAIDs require dose reduction in renal impairment. … Description and guidelines for prevention in patients with renal insufficiency. … Allopurinol-induced severe hypersensitivity with acute renal failure. … A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.

132. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
     January 01, 2015 - payers have also broadened the eligibility for treatment to include infected individuals with earlier stage … Lymphomas Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders Catheter-Based Renal … some third-party payers is to treat only those patients in advanced 10 stages of infection (stage … When added to standard intraoperative assessment during lumpectomy for early stage breast cancer, MarginProbe … Care System for Preserving Donor Lungs A double-lung transplant is a last resort for patients with end-stage

133. Use of Natriuretic Peptide Measurement in the Management of Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
     December 20, 2011 - coronary artery disease (CAD), with CAD, other adults at risk of HF without documented HF (diabetes, renal … disease has been used to include or exclude subjects (e.g., acute coronary syndrome (ACS), CAD, Diabetes, Renal … hematocrit, widened QRS interval on 12-lead electrocardiogram, chronic hypotension, resting tachycardia, renal … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

134. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - For example, intact parathyroid hormone (PTH) measurements are used to manage patients with renal osteodystrophy … Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage … renal disease patients: implication for treatment decisions.

135. Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
     November 08, 2011 - population includes patients for whom treatment is contraindicated: Pregnant women Patients with renal … all potentially eligible studies, including those that are questionable or unclear at the abstract stage … We will code the reason any articles, at the stage of the full-text review, are not included in the review … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … population include patients for whom treatment is contraindicated: Pregnant women Patients with renal

136. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - population includes patients for whom treatment is contraindicated:  Pregnant women  Patients with renal … We will code the reason any articles, at the stage of the full-text review, are not included in the … Studies at the abstract and full-review stage will be managed with Reference Manager so that we can … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … population include patients for whom treatment is contraindicated:  Pregnant women  Patients with renal

137. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - Rev 3 disc The decision to emphasize BMI and renal function as potential confounders of the diagnostic … The AHRQ report in 2006 identified both renal function and weight as potential physiological variables … Prognostic value of high sensitivity C-reactive protein, N- terminal proBNP, and cardiac troponin T and I in end … stage renal disease for subsequent death over two years. … Furthermore, at this stage of development, it is unlikely that more research as suggested under research

138. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
     December 21, 2010 - Syncope Quality of life Hospitalization Adherence to prescribed cardiovascular drug regimen Renal … aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) Renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

139. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment/research-protocol
     March 05, 2012 - systemic antibiotics (KQ 2) Allergic and hypersensitivity reactions Drug toxicity (not allergic) Major—renal … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Table 3 Table 3.

140. skin-cancer-protocol-160810 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
     August 10, 2016 - People with a limited life expectancy (e.g., the very elderly, those with terminal cancer, those with end … stage renal disease) • Subgroups defined by location or grade of lesion are also of interest: o Location … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end users, individuals are invited to serve as Key Informants and those who